Overview

Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients

Status:
Withdrawn
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn about the effectiveness of quercetin in treating and preventing CINP. Researchers also want to learn if quercetin has an effect on participant's quality of life.
Phase:
Early Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Quercetin